...
首页> 外文期刊>Archives of Toxicology >State of the art in non-animal approaches for skin sensitization testing: from individual test methods towards testing strategies
【24h】

State of the art in non-animal approaches for skin sensitization testing: from individual test methods towards testing strategies

机译:非动物性皮肤致敏性测试方法的最新发展:从单个测试方法到测试策略

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The hazard assessment of skin sensitizers relies mainly on animal testing, but much progress is made in the development, validation and regulatory acceptance and implementation of non-animal predictive approaches. In this review, we provide an update on the available computational tools and animal-free test methods for the prediction of skin sensitization hazard. These individual test methods address mostly one mechanistic step of the process of skin sensitization induction. The adverse outcome pathway (AOP) for skin sensitization describes the key events (KEs) that lead to skin sensitization. In our review, we have clustered the available test methods according to the KE they inform: the molecular initiating event (MIE/KE1)-protein binding, KE2-keratinocyte activation, KE3-dendritic cell activation and KE4-T cell activation and proliferation. In recent years, most progress has been made in the development and validation of in vitro assays that address KE2 and KE3. No standardized in vitro assays for T cell activation are available; thus, KE4 cannot be measured in vitro. Three non-animal test methods, addressing either the MIE, KE2 or KE3, are accepted as OECD test guidelines, and this has accelerated the development of integrated or defined approaches for testing and assessment (e.g. testing strategies). The majority of these approaches are mechanism-based, since they combine results from multiple test methods and/or computational tools that address different KEs of the AOP to estimate skin sensitization potential and sometimes potency. Other approaches are based on statistical tools. Until now, eleven different testing strategies have been published, the majority using the same individual information sources. Our review shows that some of the defined approaches to testing and assessment are able to accurately predict skin sensitization hazard, sometimes even more accurate than the currently used animal test. A few defined approaches are developed to provide an estimate of the potency sub-category of a skin sensitizer as well, but these approaches need further independent evaluation with a new dataset of chemicals. To conclude, this update shows that the field of non-animal approaches for skin sensitization has evolved greatly in recent years and that it is possible to predict skin sensitization hazard without animal testing.
机译:皮肤增敏剂的危害评估主要依靠动物试验,但在非动物预测方法的开发,验证,法规接受和实施方面取得了很大进展。在这篇综述中,我们提供了有关可用的计算工具和无动物测试方法的更新,以预测皮肤致敏危险。这些单独的测试方法主要解决了皮肤致敏诱导过程中的一个机械步骤。皮肤致敏的不良结局途径(AOP)描述了导致皮肤致敏的关键事件(KEs)。在我们的综述中,我们根据他们所了解的KE归纳了可用的测试方法:分子起始事件(MIE / KE1)-蛋白质结合,KE2-角质形成细胞活化,KE3-树突状细胞活化以及KE4-T细胞活化和增殖。近年来,在开发和验证针对KE2和KE3的体外测定法方面取得了最大进展。目前尚无用于T细胞活化的标准化体外测定方法。因此,不能在体外测量KE4。三种针对MIE,KE2或KE3的非动物测试方法被接受为OECD测试指南,这加速了集成或定义的测试和评估方法(例如测试策略)的开发。这些方法中的大多数是基于机制的,因为它们结合了多种测试方法和/或计算工具的结果,这些方法和方法解决了AOP的不同KE,从而估计了皮肤致敏的潜力,有时还包括功效。其他方法基于统计工具。到目前为止,已经发布了11种不同的测试策略,其中大多数使用相同的单个信息源。我们的评论显示,某些定义的测试和评估方法能够准确预测皮肤致敏危害,有时甚至比目前使用的动物测试更为准确。还开发了一些定义的方法来提供对皮肤敏化剂效力子类别的估计,但是这些方法需要使用新的化学数据集进行进一步的独立评估。总而言之,此更新表明,近年来,非动物性皮肤致敏方法的领域已发生了巨大变化,无需进行动物试验就可以预测皮肤致敏性危害。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号